Avidity Biosciences EBITDA 2019-2024 | RNA

Avidity Biosciences EBITDA for the quarter ending September 30, 2024 was $-0.104B, a 70.86% increase year-over-year.

  • Avidity Biosciences 2023 EBITDA was -0.245B, a 37.4% increase from 2022.
  • Avidity Biosciences 2022 EBITDA was -0.178B, a 51.95% increase from 2021.
  • Avidity Biosciences 2021 EBITDA was -0.117B, a 167.08% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Avidity Biosciences EBITDA 2019-2024 | RNA

  • Avidity Biosciences 2023 EBITDA was -0.245B, a 37.4% increase from 2022.
  • Avidity Biosciences 2022 EBITDA was -0.178B, a 51.95% increase from 2021.
  • Avidity Biosciences 2021 EBITDA was -0.117B, a 167.08% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.